BDNF and psychiatric disorder: Interestingly, in animal models, it has already been established that BDNF can be the potential therapeutic target for psychiatric disorders and neurological disorders, even though the BDNF protein itself has a short half-life and can hardly penetrate the blood brain barrier [91,92,93].